Daniel Weiser Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• XPO1 is overabundant in patients with neuroblastoma at ultra-high-risk for treatment failure: rationale for refined diagnostic risk stratification and targeted therapy — Poster Session 2 with wine & cheese